Cytosorbents (CTSO) Short-term Investments (2014 - 2024)

Cytosorbents (CTSO) posted Short-term Investments of $5.0 million for Q4 2024, up 1908.03% on a QoQ basis from $249000.0 in Q2 2016.

Cytosorbents (CTSO) Short-term Investments (2014 - 2024) Analysis & Trends

Cytosorbents' Short-term Investments history runs 4 years deep, the most recent figure standing at $5.0 million for Q4 2024.

Quarterly Short-term Investments changed N/A year-over-year to $5.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $5.0 million (changed N/A YoY) and the FY2024 annual result came in at $5.0 million, changed N/A from the prior year.
Short-term Investments was $5.0 million for Q4 2024 at Cytosorbents, up from $249000.0 in the prior quarter.
Across five years, Short-term Investments topped out at $5.0 million in Q4 2024 and bottomed at $5.0 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Cytosorbents	22.58 Mn	17.78 Mn	6.13 Mn

Download Data